Title:
GLYCOGENESIS INHIBITOR
Document Type and Number:
Japanese Patent JP2006169236
Kind Code:
A
Abstract:
To provide a new diabetes-therapeutic agent having both properties of a biguanide-based medicine and a nateglinide-based medicine and reduced in adverse effects less than those of the medicines.
The new diabetes-therapeutic agent is a glycogenesis inhibitor containing corosolic acid, corosolic acid analogues or pharmaceutically permissible salts of the same as effective ingredients.
Inventors:
MATSUYAMA FUTOSHI
KIYONO YUTAKA
YAMADA YUICHIRO
HOSOKAWA MASAYA
FUJIMOTO SHINPEI
FUKUSHIMA MITSUO
UEDA NAOYA
YAMADA KOTARO
KIYONO YUTAKA
YAMADA YUICHIRO
HOSOKAWA MASAYA
FUJIMOTO SHINPEI
FUKUSHIMA MITSUO
UEDA NAOYA
YAMADA KOTARO
Application Number:
JP2005332012A
Publication Date:
June 29, 2006
Filing Date:
November 16, 2005
Export Citation:
Assignee:
YUUSU TECHNO CORP KK
International Classes:
A61K31/56; A61P3/08; A61P3/10; C07J63/00
Attorney, Agent or Firm:
Yoshiki Hasegawa
Shiro Terasaki
Shiro Terasaki
Previous Patent: SOLVENT SOLUBLE BACTERICIDE AND METHOD FOR PRODUCING THE SOLVENT SOLUBLE BACTERICIDE
Next Patent: MEDICAMENT-CONTAINING PATCH
Next Patent: MEDICAMENT-CONTAINING PATCH